ACER
Price:
$0.6601
Market Cap:
$0
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease; ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms; and ACER-2820 (emetine), a host-directed therapy against a variety of infectious diseases, including COVID...[Read more]
Industry
Biotechnology
IPO Date
2004-04-14
Stock Exchange
NASDAQ
Ticker
ACER
According to Acer Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 17.56M. This represents a change of -61.45% compared to the average of 45.54M of the last 4 quarters.
The mean historical Enterprise Value of Acer Therapeutics Inc. over the last ten years is 31.20M. The current 17.56M Enterprise Value has changed 5.53% with respect to the historical average. Over the past ten years (40 quarters), ACER's Enterprise Value was at its highest in in the September 2018 quarter at 229.91M. The Enterprise Value was at its lowest in in the June 2017 quarter at 3.21M.
Average
31.20M
Median
21.98M
Minimum
3.23M
Maximum
130.46M
Discovering the peaks and valleys of Acer Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 998.93%
Maximum Annual Enterprise Value = 130.46M
Minimum Annual Increase = -77.78%
Minimum Annual Enterprise Value = 3.23M
Year | Enterprise Value | Change |
---|---|---|
2022 | 49.11M | 142.94% |
2021 | 20.21M | -14.85% |
2020 | 23.74M | -18.09% |
2019 | 28.98M | -77.78% |
2018 | 130.46M | 267.24% |
2017 | 35.52M | 998.93% |
2016 | 3.23M | -16.58% |
2015 | 3.87M | -69.90% |
2014 | 12.87M | 226.03% |
2013 | 3.95M | -45.80% |
The current Enterprise Value of Acer Therapeutics Inc. (ACER) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
31.02M
5-year avg
50.50M
10-year avg
31.20M
Acer Therapeutics Inc.’s Enterprise Value is less than NRx Pharmaceuticals, Inc. (0), less than Pasithea Therapeutics Corp. (24.01M), greater than SAB Biotherapeutics, Inc. (-6092141.00), less than Lexaria Bioscience Corp. (33.19M), less than Navidea Biopharmaceuticals, Inc. (32.21M), greater than ZyVersa Therapeutics, Inc. (-2595051.00), greater than Biodexa Pharmaceuticals Plc (2.57M), less than Oncorus, Inc. (775.53M), less than Kiromic BioPharma, Inc. (42.71M), greater than YS Biopharma Co., Ltd. (13.26M), less than BiomX Inc. (781.11M), greater than Avenue Therapeutics, Inc. (-3907383.00), greater than Hoth Therapeutics, Inc. (935.74K), greater than Revelation Biosciences, Inc. (-2555665.00), greater than NeuroBo Pharmaceuticals, Inc. (-4029924.00), greater than Virax Biolabs Group Limited (-1181216.00), greater than null (4.10M),
Company | Enterprise Value | Market cap |
---|---|---|
0 | $18.95M | |
24.01M | $3.27M | |
-6092141.00 | $37.84M | |
33.19M | $38.57M | |
32.21M | $10.01K | |
-2595051.00 | $2.70M | |
2.57M | $996.56M | |
775.53M | $0 | |
42.71M | $1.47M | |
13.26M | $192.09M | |
781.11M | $9.88M | |
-3907383.00 | $3.53M | |
935.74K | $5.43M | |
-2555665.00 | $2.51M | |
-4029924.00 | $20.33M | |
-1181216.00 | $7.47M | |
4.10M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acer Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acer Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Acer Therapeutics Inc.'s Enterprise Value?
What is the highest Enterprise Value for Acer Therapeutics Inc. (ACER)?
What is the 3-year average Enterprise Value for Acer Therapeutics Inc. (ACER)?
What is the 5-year average Enterprise Value for Acer Therapeutics Inc. (ACER)?
How does the current Enterprise Value for Acer Therapeutics Inc. (ACER) compare to its historical average?